Filter News
Area of Research
- (-) Biology and Environment (12)
- Advanced Manufacturing (1)
- Computational Biology (1)
- Computational Engineering (1)
- Computer Science (8)
- Electricity and Smart Grid (3)
- Energy Science (46)
- Functional Materials for Energy (1)
- Fusion and Fission (3)
- Materials (13)
- National Security (18)
- Neutron Science (6)
- Quantum information Science (1)
- Sensors and Controls (1)
- Supercomputing (41)
News Topics
- (-) Artificial Intelligence (9)
- (-) Grid (3)
- 3-D Printing/Advanced Manufacturing (11)
- Advanced Reactors (1)
- Big Data (10)
- Bioenergy (46)
- Biology (74)
- Biomedical (16)
- Biotechnology (14)
- Buildings (2)
- Chemical Sciences (12)
- Clean Water (11)
- Composites (5)
- Computer Science (19)
- Coronavirus (13)
- Critical Materials (1)
- Cybersecurity (1)
- Energy Storage (7)
- Environment (91)
- Exascale Computing (4)
- Frontier (3)
- Fusion (1)
- High-Performance Computing (20)
- Hydropower (8)
- Isotopes (2)
- Machine Learning (9)
- Materials (12)
- Materials Science (6)
- Mathematics (4)
- Mercury (7)
- Microscopy (10)
- Molten Salt (1)
- Nanotechnology (7)
- National Security (3)
- Neutron Science (4)
- Nuclear Energy (1)
- Partnerships (6)
- Physics (2)
- Polymers (2)
- Security (2)
- Simulation (15)
- Summit (10)
- Transportation (3)
ORNL's Communications team works with news media seeking information about the laboratory. Media may use the resources listed below or send questions to news@ornl.gov.
1 - 10 of 12 Results

Scientists at ORNL used their expertise in quantum biology, artificial intelligence and bioengineering to improve how CRISPR Cas9 genome editing tools work on organisms like microbes that can be modified to produce renewable fuels and chemicals.

Wildfires have shaped the environment for millennia, but they are increasing in frequency, range and intensity in response to a hotter climate. The phenomenon is being incorporated into high-resolution simulations of the Earth’s climate by scientists at the Department of Energy’s Oak Ridge National Laboratory, with a mission to better understand and predict environmental change.

Nature-based solutions are an effective tool to combat climate change triggered by rising carbon emissions, whether it’s by clearing the skies with bio-based aviation fuels or boosting natural carbon sinks.

A new report published by ORNL assessed how advanced manufacturing and materials, such as 3D printing and novel component coatings, could offer solutions to modernize the existing fleet and design new approaches to hydropower.

ORNL researchers discovered genetic mutations that underlie autism using a new approach that could lead to better diagnostics and drug therapies.

When Hurricane Maria battered Puerto Rico in 2017, winds snapped trees and destroyed homes, while heavy rains transformed streets into rivers. But after the storm passed, the human toll continued to grow as residents struggled without electricity for months. Five years later, power outages remain long and frequent.

ORNL, TVA and TNECD were recognized by the Federal Laboratory Consortium for their impactful partnership that resulted in a record $2.3 billion investment by Ultium Cells, a General Motors and LG Energy Solution joint venture, to build a battery cell manufacturing plant in Spring Hill, Tennessee.

Researchers at Oak Ridge National Laboratory are using a novel approach in determining environmental impacts to aquatic species near hydropower facilities, potentially leading to smarter facility designs that can support electrical grid reliability.

A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory and the Georgia Institute of Technology is using supercomputing and revolutionary deep learning tools to predict the structures and roles of thousands of proteins with unknown functions.

The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.